Methylene blue targets mitochondria differently in healthy versus cancer cells. It stabilizes normal cell function while disrupting the abnormal metabolism that powers tumors, making them more vulnerable to other treatments.
The ones we found that are more, you could say, elegant from a medical point of view and more helpful will support normal mitochondrial function in a normal cell and harm abnormal mitochondrial function in a cancer cell. Well, it turns out we didn't realize this for a long time, but it turns out that one of those agents is methylene blue. And so methylene blue has an ability to be a mitochondrial cancer agent. Where it's gonna help your normal tissue stay normal, and it's going to help your cancerous tissue be weakened so that other therapies can then take effect.
